{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:34:16Z","timestamp":1789742056742,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Horizon Therapeutics plc"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ymgme.2020.12.002","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T03:08:16Z","timestamp":1608692896000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2\u00a0months of age with urea cycle disorders"],"prefix":"10.1016","volume":"132","author":[{"given":"Nicola","family":"Longo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Lichter-Konecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Inbar-Feigenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison A.","family":"Bannick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn E.","family":"McCandless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Zori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Hainline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Ah Mew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Canavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vescio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marty H.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2020.12.002_bb0005","unstructured":"Ah Mew N, Simpson KL, Gropman AL, et al. Urea cycle disorders overview. 2003 Apr 29 [Updated 2017 Jun 22]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132020. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1217\/"},{"issue":"4","key":"10.1016\/j.ymgme.2020.12.002_bb0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10545-012-9546-2","article-title":"Ammonia toxicity to the brain","volume":"36","author":"Braissant","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2020.12.002_bb0015","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision","volume":"42","author":"H\u00e4berle","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2020.12.002_bb0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0022-3476(86)80989-1","article-title":"Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency","volume":"108","author":"Batshaw","year":"1986","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2020.12.002_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2018.04.006","article-title":"Newborn screening for proximal urea cycle disorders: current evidence supporting recommendations for newborn screening","volume":"124","author":"Merritt","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2020.12.002_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.25492","article-title":"Impact of diagnosis and therapy on cognitive function in urea cycle disorders","volume":"86","author":"Posset","year":"2019","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.ymgme.2020.12.002_bb0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/000992280404300801","article-title":"Hyperammonemia, bane of the brain","volume":"43","author":"Cohn","year":"2004","journal-title":"Clin. Pediatr. (Phila)"},{"issue":"4","key":"10.1016\/j.ymgme.2020.12.002_bb0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17425255.2017.1262843","article-title":"An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease","volume":"13","author":"De Las Heras","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"7","key":"10.1016\/j.ymgme.2020.12.002_bb0045","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/gim.2017.167","article-title":"A randomized trial to study the comparative efficacy of phenylbutyrate and benzoate on nitrogen excretion and ureagenesis in healthy volunteers","volume":"20","author":"Nagamani","year":"2018","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2020.12.002_bb0050","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ymgme.2010.02.007","article-title":"Nitrogen sparing therapy revisited 2009","volume":"100","author":"Enns","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2020.12.002_bb0055","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJM199609193351204","article-title":"Long-term treatment of girls with ornithine transcarbamylase deficiency","volume":"335","author":"Maestri","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2020.12.002_bb0060","first-page":"15","article-title":"Drugs for rare diseases: ravicti for urea cycle disorders as a case study","volume":"2","author":"Le Mons","year":"2013","journal-title":"Wharton Healthcare Quart."},{"issue":"6","key":"10.1016\/j.ymgme.2020.12.002_bb0065","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/hep.26106","article-title":"Rare disease clinical research network\u2019s urea cycle consortium delivers a successful clinical trial to improve alternate pathway therapy","volume":"57","author":"Mistry","year":"2013","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"7","key":"10.1016\/j.ymgme.2020.12.002_bb0070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jcph.92","article-title":"Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult and pediatric patients with urea cycle disorders","volume":"53","author":"Monteleone","year":"2013","journal-title":"J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ymgme.2020.12.002_bb0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymgme.2010.04.008","article-title":"Alternative pathway or diversion therapy for urea cycle disorders now and in the future","volume":"100","author":"Cederbaum","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2020.12.002_bb0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymgme.2017.09.002","article-title":"Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2 months to 2 years","volume":"122","author":"Berry","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2020.12.002_bb0085","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/hep.26058","article-title":"Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate","volume":"57","author":"Diaz","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ymgme.2020.12.002_bb0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ymgme.2010.03.014","article-title":"Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control","volume":"100","author":"Lee","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2020.12.002_bb0095","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ymgme.2011.04.013","article-title":"Ammonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate","volume":"103","author":"Lichter-Konecki","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2020.12.002_bb0100","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.jpeds.2012.11.084","article-title":"Ammonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrate","volume":"162","author":"Smith","year":"2013","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2020.12.002_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ymgme.2014.02.007","article-title":"Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes","volume":"112","author":"Berry","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2020.12.002_bb0110","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymgme.2019.07.004","article-title":"Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients","volume":"127","author":"Diaz","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2020.12.002_bb0115","first-page":"131","article-title":"Hyperammonemic crises in patients with urea cycle disorders on chronic nitrogen scavenger therapy with either sodium phenylbutyrate or glycerol phenylbutyrate","volume":"7","author":"Kent","year":"2017","journal-title":"Neuropsychiatry (London)"},{"issue":"6","key":"10.1016\/j.ymgme.2020.12.002_bb0120","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/hep.23589","article-title":"Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis","volume":"51","author":"McGuire","year":"2010","journal-title":"Hepatology (Baltimore, Md)."},{"key":"10.1016\/j.ymgme.2020.12.002_bb0125","series-title":"Ravicti [package insert]","year":"2019"},{"issue":"4","key":"10.1016\/j.ymgme.2020.12.002_bb0130","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymgme.2013.09.017","article-title":"Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio","volume":"110","author":"Mokhtarani","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.ymgme.2020.12.002_bb0135","first-page":"1690","article-title":"A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer","volume":"54","author":"Thibault","year":"1994","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2020.12.002_bb0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2014.08.001","article-title":"A longitudinal study of urea cycle disorders","volume":"113","author":"Batshaw","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.12.002_bb0145","first-page":"43","article-title":"Barriers to drug adherence in the treatment of urea cycle disorders: assessment of patient, caregiver and provider perspectives","volume":"8","author":"Shchelochkov","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"12","key":"10.1016\/j.ymgme.2020.12.002_bb0150","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/21678707.2017.1405807","article-title":"Glycerol phenylbutyrate for the maintenance treatment of patients with deficiencies in enzymes of the urea cycle","volume":"5","author":"Longo","year":"2017","journal-title":"Exp. Opin. Orphan Drugs"},{"issue":"6","key":"10.1016\/j.ymgme.2020.12.002_bb0155","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/jimd.12146","article-title":"Neuropsychological attributes of urea cycle disorders: a systematic review of the literature","volume":"42","author":"Waisbren","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"R1","key":"10.1016\/j.ymgme.2020.12.002_bb0160","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1093\/hmg\/ddz140","article-title":"Progress and challenges in development of new therapies for urea cycle disorders","volume":"28","author":"Soria","year":"2019","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.ymgme.2020.12.002_bb0165","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.transproceed.2015.09.020","article-title":"Liver transplantation for urea cycle disorders: analysis of the united network for organ sharing database","volume":"47","author":"Yu","year":"2015","journal-title":"Transplant. Proc."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220302705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220302705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:26:27Z","timestamp":1761089187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220302705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1096719220302705"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.12.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2\u00a0months of age with urea cycle disorders","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}